Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) - Net Assets

Latest as of September 2025: CN¥9.02 Billion CNY ≈ $1.32 Billion USD

Based on the latest financial reports, Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has net assets worth CN¥9.02 Billion CNY (≈ $1.32 Billion USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥11.59 Billion ≈ $1.70 Billion USD) and total liabilities (CN¥2.56 Billion ≈ $374.76 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 600329 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥9.02 Billion
% of Total Assets	77.89%
Annual Growth Rate	8.01%
5-Year Change	31.93%
10-Year Change	91.22%
Growth Volatility	12.0

Tianjin Zhongxin Pharmaceutical Group Corp Ltd - Net Assets Trend (1998–2024)

This chart illustrates how Tianjin Zhongxin Pharmaceutical Group Corp Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Tianjin Zhongxin Pharmaceutical Group Co assets under control for the complete picture of this company's asset base.

Annual Net Assets for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (1998–2024)

The table below shows the annual net assets of Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 1998 to 2024. For live valuation and market cap data, see how much is Tianjin Zhongxin Pharmaceutical Group Co worth.

Year	Net Assets	Change
2024-12-31	CN¥7.85 Billion ≈ $1.15 Billion	+18.13%
2023-12-31	CN¥6.65 Billion ≈ $972.41 Million	+1.42%
2022-12-31	CN¥6.55 Billion ≈ $958.76 Million	+0.59%
2021-12-31	CN¥6.51 Billion ≈ $953.18 Million	+9.48%
2020-12-31	CN¥5.95 Billion ≈ $870.66 Million	+7.73%
2019-12-31	CN¥5.52 Billion ≈ $808.22 Million	+9.28%
2018-12-31	CN¥5.05 Billion ≈ $739.62 Million	+9.27%
2017-12-31	CN¥4.63 Billion ≈ $676.85 Million	+7.51%
2016-12-31	CN¥4.30 Billion ≈ $629.56 Million	+4.80%
2015-12-31	CN¥4.11 Billion ≈ $600.72 Million	+39.32%
2014-12-31	CN¥2.95 Billion ≈ $431.19 Million	+14.43%
2013-12-31	CN¥2.57 Billion ≈ $376.80 Million	+13.00%
2012-12-31	CN¥2.28 Billion ≈ $333.46 Million	+3.34%
2011-12-31	CN¥2.21 Billion ≈ $322.67 Million	+5.66%
2010-12-31	CN¥2.09 Billion ≈ $305.38 Million	+16.71%
2009-12-31	CN¥1.79 Billion ≈ $261.66 Million	+21.42%
2008-12-31	CN¥1.47 Billion ≈ $215.50 Million	+9.45%
2007-12-31	CN¥1.35 Billion ≈ $196.89 Million	-4.45%
2006-12-31	CN¥1.41 Billion ≈ $206.07 Million	-27.74%
2005-12-31	CN¥1.95 Billion ≈ $285.17 Million	+3.80%
2004-12-31	CN¥1.88 Billion ≈ $274.74 Million	+2.11%
2003-12-31	CN¥1.84 Billion ≈ $269.08 Million	+8.85%
2002-12-31	CN¥1.69 Billion ≈ $247.19 Million	+9.61%
2001-12-31	CN¥1.54 Billion ≈ $225.52 Million	+33.86%
2000-12-31	CN¥1.15 Billion ≈ $168.48 Million	+0.77%
1999-12-31	CN¥1.14 Billion ≈ $167.20 Million	+7.89%
1998-12-31	CN¥1.06 Billion ≈ $154.97 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Tianjin Zhongxin Pharmaceutical Group Corp Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 7568.3% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥5.64 Billion	71.84%
Common Stock	CN¥770.09 Million	9.82%
Other Comprehensive Income	CN¥572.05 Million	7.29%
Other Components	CN¥866.42 Million	11.05%
Total Equity	CN¥7.84 Billion	100.00%

Tianjin Zhongxin Pharmaceutical Group Corp Ltd Competitors by Market Cap

The table below lists competitors of Tianjin Zhongxin Pharmaceutical Group Corp Ltd ranked by their market capitalization.

Company	Market Cap
Procter & Gamble Hygiene and Health Care Limited NSE:PGHH	$3.50 Billion
CIE Automotive S.A. MC:CIE	$3.50 Billion
Tofas Turk Otomobil Fabrikasi AS IS:TOASO	$3.50 Billion
Minmetals Capital Co Ltd SHG:600390	$3.50 Billion
Maximus Inc NYSE:MMS	$3.49 Billion
Regis Resources Ltd AU:RRL	$3.49 Billion
CommVault Systems Inc NASDAQ:CVLT	$3.49 Billion
Gulfport Energy Operating Corp NYSE:GPOR	$3.49 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Tianjin Zhongxin Pharmaceutical Group Corp Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 6,600,690,542 to 7,843,592,378, a change of 1,242,901,836 (18.8%).
Net income of 2,229,334,241 contributed positively to equity growth.
Dividend payments of 1,010,588,611 reduced retained earnings.
Share repurchases of 282,342 reduced equity.
Other comprehensive income decreased equity by 15,665,335.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥2.23 Billion	+28.42%
Dividends Paid	CN¥1.01 Billion	-12.88%
Share Repurchases	CN¥282.34K	-0.0%
Other Comprehensive Income	CN¥-15.67 Million	-0.2%
Other Changes	CN¥40.10 Million	+0.51%
Total Change	CN¥-	18.83%

Book Value vs Market Value Analysis

This analysis compares Tianjin Zhongxin Pharmaceutical Group Corp Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.12x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 28.99x to 4.12x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2000-12-31	CN¥1.44	CN¥41.85	x
2001-12-31	CN¥1.97	CN¥41.85	x
2002-12-31	CN¥2.05	CN¥41.85	x
2003-12-31	CN¥2.17	CN¥41.85	x
2004-12-31	CN¥2.18	CN¥41.85	x
2005-12-31	CN¥2.22	CN¥41.85	x
2006-12-31	CN¥1.63	CN¥41.85	x
2007-12-31	CN¥1.51	CN¥41.85	x
2008-12-31	CN¥1.68	CN¥41.85	x
2009-12-31	CN¥2.06	CN¥41.85	x
2010-12-31	CN¥2.45	CN¥41.85	x
2011-12-31	CN¥2.51	CN¥41.85	x
2012-12-31	CN¥2.91	CN¥41.85	x
2013-12-31	CN¥3.30	CN¥41.85	x
2014-12-31	CN¥3.71	CN¥41.85	x
2015-12-31	CN¥5.21	CN¥41.85	x
2016-12-31	CN¥5.37	CN¥41.85	x
2017-12-31	CN¥5.83	CN¥41.85	x
2018-12-31	CN¥6.40	CN¥41.85	x
2019-12-31	CN¥7.01	CN¥41.85	x
2020-12-31	CN¥7.55	CN¥41.85	x
2021-12-31	CN¥8.28	CN¥41.85	x
2022-12-31	CN¥8.40	CN¥41.85	x
2023-12-31	CN¥8.56	CN¥41.85	x
2024-12-31	CN¥10.17	CN¥41.85	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Tianjin Zhongxin Pharmaceutical Group Corp Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 28.42%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 30.51%
• Asset Turnover: 0.68x
• Equity Multiplier: 1.37x
Recent ROE (28.42%) is above the historical average (9.53%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2000	8.14%	10.51%	0.33x	2.38x	CN¥-19.82 Million
2001	4.37%	4.16%	0.56x	1.88x	CN¥-81.67 Million
2002	5.65%	4.63%	0.61x	2.00x	CN¥-65.56 Million
2003	5.42%	4.19%	0.54x	2.38x	CN¥-73.04 Million
2004	3.99%	3.04%	0.54x	2.44x	CN¥-96.38 Million
2005	4.95%	3.23%	0.62x	2.49x	CN¥-82.36 Million
2006	-32.19%	-17.86%	0.62x	2.92x	CN¥-506.64 Million
2007	-6.30%	-3.10%	0.65x	3.13x	CN¥-180.92 Million
2008	14.25%	7.45%	0.69x	2.79x	CN¥52.57 Million
2009	16.97%	8.95%	0.79x	2.41x	CN¥105.85 Million
2010	16.30%	8.44%	0.91x	2.13x	CN¥113.31 Million
2011	13.15%	5.64%	1.06x	2.20x	CN¥59.39 Million
2012	20.65%	8.60%	1.16x	2.07x	CN¥227.61 Million
2013	14.55%	5.85%	1.14x	2.18x	CN¥110.06 Million
2014	12.95%	5.05%	1.30x	1.97x	CN¥81.42 Million
2015	11.51%	6.38%	1.17x	1.55x	CN¥59.27 Million
2016	10.23%	6.79%	0.98x	1.54x	CN¥9.63 Million
2017	10.63%	8.37%	0.86x	1.48x	CN¥28.40 Million
2018	11.40%	8.83%	0.89x	1.44x	CN¥68.98 Million
2019	11.61%	8.94%	0.89x	1.46x	CN¥86.75 Million
2020	11.39%	10.02%	0.80x	1.43x	CN¥80.86 Million
2021	12.08%	11.13%	0.76x	1.42x	CN¥132.70 Million
2022	13.21%	10.45%	0.81x	1.56x	CN¥209.65 Million
2023	14.95%	12.00%	0.80x	1.55x	CN¥326.64 Million
2024	28.42%	30.51%	0.68x	1.37x	CN¥1.44 Billion

Industry Comparison

This section compares Tianjin Zhongxin Pharmaceutical Group Corp Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $4,691,234,838
Average return on equity (ROE) among peers: 6.16%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)	CN¥9.02 Billion	8.14%	0.28x	$3.49 Billion
Shenzhen Neptunus Bioengineering Co Ltd (000078)	$903.62 Million	4.28%	2.45x	$1.16 Billion
Anhui Fengyuan Pharmaceutical Co Ltd (000153)	$1.22 Billion	5.35%	1.27x	$441.99 Million
Shan Dong Dong-E E-Jiao Co Ltd (000423)	$9.87 Billion	20.71%	0.25x	$5.01 Billion
Livzon Pharmaceutical Group Inc (000513)	$1.07 Billion	3.83%	0.46x	$2.80 Billion
Wedge Industrial Co Ltd (000534)	$1.15 Billion	11.42%	1.59x	$3.04 Billion
Yunnan Baiyao Group Co Ltd (000538)	$9.03 Billion	25.71%	0.43x	$13.75 Billion
Hainan Haiyao Co Ltd (000566)	$275.57 Million	17.28%	1.12x	$947.33 Million
Tus Pharmaceutical Group Co Ltd (000590)	$231.22 Million	-38.13%	1.23x	$389.67 Million
Northeast Pharmaceutical Group Co Ltd (000597)	$4.29 Billion	2.31%	2.07x	$1.03 Billion
Jilin Aodong Pharmaceutical Group Co Ltd (000623)	$18.87 Billion	8.83%	0.08x	$3.32 Billion

About Tianjin Zhongxin Pharmaceutical Group Corp Ltd

SHG:600329 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.49 Billion

CN¥23.86 Billion CNY

Market Cap Rank

#4538 Global

#823 in China

Share Price

CN¥41.85

Change (1 day)

+3.08%

52-Week Range

CN¥29.79 - CN¥50.05

All Time High

CN¥54.12